Cervical Carcinoma
📧 Sign up to get email alerts when something new happens for Cervical Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma [Phase 2]
Phase 2 trial of LN-145 autologous tumor-infiltrating lymphocytes in cervical carcinoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial updating PRGN-2009 in combination with pembrolizumab for recurrent or metastatic cervical cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT [Phase 3]
Phase 3 clinical trial assessing cadonilimab with chemotherapy followed by concurrent chemoradiation for locally advanced cervical carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]
Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma [Phase 2]
Phase 2 study of LN-145 autologous tumor-infiltrating lymphocytes for cervical carcinoma has been terminated with no further enrollment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers [Phase 1]
Phase 1 trial updating on AZD1775 in combination with radiotherapy and chemotherapy for cervical, upper vaginal, and uterine cancers; study …
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Tislelizumab and Radiotherapy for Recurrent Cervical Cancer [Phase 2]
A phase 2 clinical trial evaluating tislelizumab in combination with radiotherapy for recurrent/metastatic cervical cancer; current status a…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial [Phase 2]
A phase 2 multi-center trial evaluating immunotherapy for recurrent cervical cancer that is refractory to platinum-based chemotherapy is in …
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy [Phase 2]
Phase 2 trial update evaluating immunotherapy for recurrent or persistent advanced cervical carcinoma refractory to platinum-based chemother…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: First-line Chemotherapy for Recurrent Cervical Cancer [Phase 2]
Phase 2 trial update for first-line chemotherapy in recurrent/persistent advanced cervical cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies [Phase 2]
Phase 2 clinical trial of selinexor (KPT-330) in female patients with advanced gynecologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial evaluating camrelizumab with chemotherapy for recurrent or advanced cervical neuroendocrine carcinomas; status and detailed re…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial updating vaccine therapy for persistent or recurrent cervical cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update for ABI-007 in persistent or recurrent cervical cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating docetaxel for persistent or recurrent cervical cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial evaluating veliparib with topotecan and G-CSF support in persistent or recurrent cervical cancer has completed with posted res…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Phase 2 trial of brivanib alaninate in persistent or recurrent cervical cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel and cisplatin or topotecan with or without bevacizumab in stage IVB, recurrent, or persistent cervical…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Ixabepilone to Treat Cervical Cancer [Phase 2]
Phase 2 trial of ixabepilone for cervical cancer has been terminated; results posted in 2014.